Correlation Between Fate Therapeutics and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Fate Therapeutics and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Artiva Biotherapeutics,.
Diversification Opportunities for Fate Therapeutics and Artiva Biotherapeutics,
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Fate and Artiva is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Artiva Biotherapeutics,
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Artiva Biotherapeutics,. In addition to that, Fate Therapeutics is 1.01 times more volatile than Artiva Biotherapeutics, Common. It trades about -0.09 of its total potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.01 per unit of volatility. If you would invest 1,200 in Artiva Biotherapeutics, Common on October 14, 2024 and sell it today you would lose (265.00) from holding Artiva Biotherapeutics, Common or give up 22.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 65.59% |
| Values | Daily Returns |
Fate Therapeutics vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Fate Therapeutics |
| Artiva Biotherapeutics, |
Fate Therapeutics and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and Artiva Biotherapeutics,
The main advantage of trading using opposite Fate Therapeutics and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
| Artiva Biotherapeutics, vs. Oatly Group AB | Artiva Biotherapeutics, vs. National Beverage Corp | Artiva Biotherapeutics, vs. SNDL Inc | Artiva Biotherapeutics, vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world |